XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 27, 2025
Dec. 28, 2024
Dec. 27, 2025
Dec. 28, 2024
Income Statement [Abstract]        
Net sales $ 96,319 $ 113,853 $ 195,069 $ 245,411
Cost of sales 95,759 106,147 186,255 224,402
Gross profit 560 7,706 8,814 21,009
Research, development and engineering expenses 1,844 2,320 3,923 4,609
Selling, general and administrative expenses 8,974 6,507 15,733 13,077
Total operating expenses 10,818 8,827 19,656 17,686
Operating income (loss) (10,258) (1,121) (10,842) 3,323
Interest expense, net 2,371 3,904 5,147 7,167
Loss before income taxes (12,629) (5,025) (15,989) (3,844)
Income tax benefit (4,059) (111) (5,164) (54)
Net loss $ (8,570) $ (4,914) $ (10,825) $ (3,790)
Net loss per share — Basic (in USD per share) $ (0.79) $ (0.46) $ (1.00) $ (0.35)
Weighted average shares outstanding — Basic (in shares) 10,859 10,762 10,815 10,762
Net loss per share — Diluted (in USD per share) $ (0.79) $ (0.46) $ (1.00) $ (0.35)
Weighted average shares outstanding — Diluted (in shares) 10,859 10,762 10,815 10,762